Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice
Open Access
- 3 August 2010
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (8), 2424-2431
- https://doi.org/10.1002/art.27534
Abstract
Objective Skin disease is the second most common manifestation in patients with systemic lupus erythematosus (SLE). Tumor necrosis factor receptor (TNFR) preligand assembly domain (PLAD) has been found to block the effect of TNFα, and TNFRI PLAD (p60 PLAD) inhibits inflammatory arthritis. This study was undertaken to investigate whether TNFR PLAD limits inflammatory skin injury in a mouse model of SLE. Methods Female MRL/lpr mice received p60 PLAD (100 μg/mouse intraperitoneally), p80 PLAD (100 μg/mouse intraperitoneally), or phosphate buffered saline (100 μl/mouse intraperitoneally) 3 times a week for 26 weeks, starting at age 6 weeks. Results Immunohistochemistry studies demonstrated that TNFRI but not TNFRII was dominantly expressed in skin lesions in MRL/lpr mice. We found that TNFRI PLAD (p60 PLAD) but not TNFRII PLAD (p80 PLAD) protein significantly inhibited skin injury in the MRL/lpr mouse model of lupus. NF‐κB, monocyte chemotactic protein 1, and inducible nitric oxide synthase expression in skin lesions were significantly inhibited by p60 PLAD. Lupus serum–induced monocyte differentiation into dendritic cells was reduced by p60 PLAD, but p60 PLAD did not reduce IgG deposition in the skin or improve the progression of kidney damage in MRL/lpr mice. Conclusion Our results indicate that TNFRI is involved in the expression of skin injury in MRL/lpr mice with lupus and that p60 PLAD or similar biologics may be of clinical value if applied locally.Keywords
This publication has 33 references indexed in Scilit:
- Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic CellsAnnual Review of Immunology, 2009
- Nephritogenic Lupus Antibodies Recognize Glomerular Basement Membrane-Associated Chromatin Fragments Released from Apoptotic Intraglomerular CellsThe American Journal of Pathology, 2006
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2Nature, 2002
- Increased nitric oxide production accompanied by the up‐regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosusArthritis & Rheumatism, 1997
- Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF‐α‐induced skin inflammationEuropean Journal of Immunology, 1997
- Antigen specificity of anti‐nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivoEuropean Journal of Immunology, 1997
- Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling.The Journal of Experimental Medicine, 1996
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.JCI Insight, 1994